Form 4: Enanta Pharmaceuticals' Chief Medical Officer Reports Stock Transactions
SEC Form 4 Filing
Scott Rottinghaus, Chief Medical Officer of Enanta Pharmaceuticals, reports the forfeiture of shares to cover withholding taxes related to restricted stock unit settlements.
Summary
- Scott Rottinghaus, the Chief Medical Officer of Enanta Pharmaceuticals, filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
- On August 8, 2023, 1,467 shares were forfeited at a price of $17.23 to cover withholding taxes due to the settlement of a portion of a restricted stock unit award granted on August 8, 2022.
- On August 8, 2024, 1,466 shares were forfeited at a price of $12.73 to cover withholding taxes due to the settlement of a portion of a restricted stock unit award granted on August 8, 2022.
- Following these transactions, Rottinghaus directly owns 18,784 shares of Enanta Pharmaceuticals.
- Rottinghaus has also granted a Power of Attorney to Jay R. Luly, Paul J. Mellett, Matthew P. Kowalsky, Stacie Aarestad and Ryan Rourke Reed to execute and file SEC forms on his behalf.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions. The sentiment is neutral as it reflects standard compensation practices.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors to gauge management's sentiment and confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 08/08/2022 | Date of restricted stock unit award grant. |
| 08/08/2023 | Date of first stock forfeiture transaction at $17.23. |
| 08/08/2024 | Date of second stock forfeiture transaction at $12.73. |
| 08/09/2024 | Date of signature on the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.